{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:27:30Z","timestamp":1791300450681,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10557-010-6262-8","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T10:53:20Z","timestamp":1283252000000},"page":"373-378","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of Simvastatin in Reducing Aortic Dilatation in Mouse Models of Abdominal Aortic Aneurysm"],"prefix":"10.1007","volume":"24","author":[{"given":"Jonathan","family":"Golledge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,12]]},"reference":[{"key":"6262_CR1","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.ATV.0000245819.32762.cb","volume":"26","author":"J Golledge","year":"2006","unstructured":"Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26:2605\u201313.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6262_CR2","doi-asserted-by":"crossref","unstructured":"Propanolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg. 2002;35:72\u20139.","DOI":"10.1067\/mva.2002.121308"},{"key":"6262_CR3","first-page":"52","volume":"18","author":"JS Lindholt","year":"1999","unstructured":"Lindholt JS, Henneberg EW, Juul S, Fasting H. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Int Angiol. 1999;18:52\u20137.","journal-title":"Int Angiol"},{"key":"6262_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2168.2000.01420-23.x","volume":"87","author":"AB Wilmink","year":"2000","unstructured":"Wilmink AB, Hubbard CS, Day NE, Quick CR. Effect of propanolol on the expansion of abdominal aortic aneurysms: a randomised study. Br J Surg. 2000;87:499.","journal-title":"Br J Surg"},{"key":"6262_CR5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mva.2001.117891","volume":"34","author":"M Mosorin","year":"2001","unstructured":"Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg. 2001;34:606\u201310.","journal-title":"J Vasc Surg"},{"key":"6262_CR6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.0007-1323.2001.01845.x","volume":"88","author":"S Vammen","year":"2001","unstructured":"Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg. 2001;88:1066\u201372.","journal-title":"Br J Surg"},{"key":"6262_CR7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.sla.0000150258.36236.e0","volume":"241","author":"EF Steinmetz","year":"2005","unstructured":"Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D, et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg. 2005;241:92\u2013101.","journal-title":"Ann Surg"},{"key":"6262_CR8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/ATVBAHA.109.192609","volume":"29","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Naggar JC, Welzig CM, Beasley D, Moulton KS, Park HJ, et al. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol. 2009;29:1764\u201371.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6262_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.atherosclerosis.2009.03.028","volume":"206","author":"K Kajimoto","year":"2009","unstructured":"Kajimoto K, Miyauchi K, Kasai T, Shimada K, Kojima Y, Shimada A, et al. Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis 2009;206:505\u201311.","journal-title":"Atherosclerosis"},{"key":"6262_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.atherosclerosis.2009.02.014","volume":"206","author":"K Nakamura","year":"2009","unstructured":"Nakamura K, Sasaki T, Cheng XW, Iguchi A, Sato K, Kuzuya M. Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation. Atherosclerosis 2009;206:355\u201361.","journal-title":"Atherosclerosis"},{"key":"6262_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.CIR.0000022843.76104.01","volume":"106","author":"Z Chen","year":"2002","unstructured":"Chen Z, Fukutomi T, Zago AC, Ehlers R, Detmers PA, Wright SD, et al. Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids. Circulation 2002;106:20\u20133.","journal-title":"Circulation"},{"key":"6262_CR12","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.177.5.3028","volume":"177","author":"T Aprahamian","year":"2006","unstructured":"Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, Rifkin IR, et al. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. Immunol 2006;177:3028\u201334.","journal-title":"Immunol"},{"key":"6262_CR13","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/S0022-2275(20)30035-3","volume":"38","author":"CL Bisgaier","year":"1997","unstructured":"Bisgaier CL, Essenburg AD, Auerbach BJ, Pape ME, Sekerke CS, Gee A, et al. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors. J Lipid Res. 1997;38:2502\u201315.","journal-title":"J Lipid Res"},{"key":"6262_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.RES.0000202706.70992.95","volume":"98","author":"R Paumelle","year":"2006","unstructured":"Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G, et al. Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res. 2006;98:361\u20139.","journal-title":"Circ Res"},{"key":"6262_CR15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.ATV.0000058404.92759.32","volume":"23","author":"MW Manning","year":"2003","unstructured":"Manning MW, Cassis LA, Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2003;23:483\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6262_CR16","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/01.CIR.0000163544.17221.BE","volume":"111","author":"YX Wang","year":"2005","unstructured":"Wang YX, Martin-McNulty B, da Cunha V, Vincelette J, Lu X, Feng Q, et al. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and pro6teolysis. Circulation 2005;111:2219\u201326.","journal-title":"Circulation"},{"key":"6262_CR17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/nm1335","volume":"11","author":"K Yoshimura","year":"2005","unstructured":"Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med. 2005;11:1330\u20138.","journal-title":"Nat Med"},{"key":"6262_CR18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.0000216119.79008.ac","volume":"26","author":"VL King","year":"2006","unstructured":"King VL, Trivedi D, Gitlin JM, Loftin CD. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vasc Biol. 2006;26:1137\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6262_CR19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.ATV.0000085842.20866.6A","volume":"23","author":"B Martin-McNulty","year":"2003","unstructured":"Martin-McNulty B, Tham DM, da Cunha V, Ho JJ, Wilson DW, Rutledge JC, et al. 17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:1627\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6262_CR20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-10-298","volume":"10","author":"C Rush","year":"2009","unstructured":"Rush C, Nyara M, Moxon JV, Trollope A, Cullen B, Golledge J. Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm. BMC Genomics. 2009;10:298.","journal-title":"BMC Genomics"},{"key":"6262_CR21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.atherosclerosis.2009.11.001","volume":"210","author":"J Golledge","year":"2010","unstructured":"Golledge J, Cullen B, Rush C, Moran CS, Secomb E, Wood F, et al. Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm. Atherosclerosis 2010;210:88\u201393.","journal-title":"Atherosclerosis"},{"key":"6262_CR22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000163019","volume":"46","author":"CS Moran","year":"2009","unstructured":"Moran CS, Cullen B, Campbell JH, Golledge J. Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm. J Vasc Res. 2009;46:209\u201317.","journal-title":"J Vasc Res"},{"key":"6262_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.ATV.0000254680.71485.92","volume":"27","author":"LA Cassis","year":"2007","unstructured":"Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol. 2007;27:380\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6262_CR24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9150(02)00387-8","volume":"167","author":"F Bea","year":"2003","unstructured":"Bea F, Blessing E, Shelley MI, Shultz JM, Rosenfeld ME. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Atherosclerosis 2003;167:187\u201394.","journal-title":"Atherosclerosis"},{"key":"6262_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejvs.2005.12.024","volume":"32","author":"O Schouten","year":"2006","unstructured":"Schouten O, van Laanen JH, Boersma E, Vidakovic R, Feringa HH, Dunkelgr\u00fcn M, et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006;32:21\u20136.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"6262_CR26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1510\/icvts.2008.178103","volume":"7","author":"M Mosorin","year":"2008","unstructured":"Mosorin M, Niemel\u00e4 E, Heikkinen J, Lahtinen J, Tiozzo V, Satta J, et al. The use of statins and fate of small abdominal aortic aneurysms. Interact Cardiovasc Thorac Surg. 2008;7:578\u201381.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"6262_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ahj.2009.11.016","volume":"159","author":"C Ferguson","year":"2010","unstructured":"Ferguson C, Clancy P, Bourke B, Walker P, Dear A, Buckenham T, et al. Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J. 2010;159:307\u201313.","journal-title":"Am Heart J"},{"key":"6262_CR28","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.108.817619","volume":"119","author":"SH Forsdahl","year":"2009","unstructured":"Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Troms\u00f8 Study, 1994\u20132001. Circulation 2009;119:2202\u20138.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-010-6262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-010-6262-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-010-6262-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T17:50:44Z","timestamp":1636307444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-010-6262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":28,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["6262"],"URL":"https:\/\/doi.org\/10.1007\/s10557-010-6262-8","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}